Stratec SE (ETR: SBS)

Market Cap	352.52M
Revenue (ttm)	250.54M
Net Income (ttm)	10.01M
Shares Out	12.16M
EPS (ttm)	0.82
PE Ratio	35.37
Forward PE	17.70
Dividend	0.55 (1.90%)
Ex-Dividend Date	n/a

Volume	11,247
Open	28.20
Previous Close	28.80
Day's Range	27.45 - 29.25
52-Week Range	26.05 - 48.60
Beta	0.16
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 27, 2025

About Stratec SE

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headqu...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2018
• Employees: 1,480
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: SBS

Financial Performance

In 2023, Stratec SE's revenue was 261.91 million, a decrease of -4.63% compared to the previous year's 274.63 million. Earnings were 13.07 million, a decrease of -55.29%.